Kopsuvähk kliinilised uuringud osariigis Alabama
16 uuringut haiguse Kopsuvähk jaoks otsivad osalejaid osariigis Alabama.
Linnad osariigis Alabama
Ametlik uuringutekst (inglise keeles)
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- Alabama Oncology, Birmingham
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT06881784Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07489066A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- University of Alabama at Birmingham, Birmingham
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07154290A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- University of Alabama at Birmingham, Birmingham
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT06618287Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- Birmingham Hematology and Oncology Associates LLC d/b/a Alabama Oncology, Birmingham
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT06712316Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Alabama Birmingham, Birmingham
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 10. sept 2026 · NCT06293898A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT06119581Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- O'Neal Comprehensive Cancer Center at UAB, Birmingham
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT06343402Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
- The Kirklin Clinic at Acton Road, Birmingham
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
- ja veel 3
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 17. aug 2026 · NCT05624996Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
- Thomas Hospital, Fairhope
- Mobile Infirmary Medical Center, Mobile
- ja veel 1
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. juuni 2026 · NCT05642572MYLUNG Consortium Part 3: Observational Study
- Southern Cancer Center, PC, Daphne
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 18. mai 2026 · NCT05885698Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
- Thomas Hospital, Fairhope
- Mobile Infirmary Medical Center, Mobile
- ja veel 1
VärbamineFaas 2
18 Minutes · Kõik sood · Uuendatud 5. mai 2026 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
- Thomas Hospital, Fairhope
- Mobile Infirmary Medical Center, Mobile
- ja veel 1
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 5. mai 2026 · NCT06616584Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. apr 2026 · NCT05297734SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
VärbamineVaatlusuuring
Kõik vanused · Kõik sood · Uuendatud 28. okt 2025 · NCT03452774A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
- XCancer Research Network/Dothan Hematology & Oncology, Dothan
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. okt 2025 · NCT06228326Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.